Two-Year Safety and Efficacy Outcomes with Fostamatinib in Adult Patients with Immune Thrombocytopenia (ITP): Open-Label Extension to Phase 3 Trial ProgramAnne‐Marie Duliège, James B. Bussel, Darla Liles et al.|Blood|2018Cited by 12
Mammalian Recombinant Coagulation Proteins: Structure and FunctionGilbert White, Harold R. Roberts, Edward M Pickens et al.|Transfusion Science|1998Cited by 11
S853 SUCCESSOR: A MULTICENTER RETROSPECTIVE NONINTERVENTIONAL FOLLOW‐UP STUDY IN PATIENTS WITH SICKLE CELL PAIN CRISES WHO PREVIOUSLY PARTICIPATED IN THE SUSTAIN TRIAL IN THE UNITED STATESDarla Liles, Ali İrfan Kutlar, Nilesh Shah et al.|HemaSphere|2019Cited by 5
Long‐term biological effects in sickle cell disease: insights from a post‐crizanlizumab studyDarla Liles, Abdullah Kutlar, Nirmish Shah et al.|British Journal of Haematology|2021Cited by 5